FTD, or frontotemporal dementia, is a group of brain disorders caused by progressive nerve cell damage in the frontal and temporal lobes. These are the areas behind your forehead and above your ears, responsible for personality, behavior, decision-making, and language. Unlike Alzheimer’s disease, which typically strikes after age 65, FTD has a mean onset age of about 53, making it one of the most common causes of dementia in younger adults.
The Three Main Types of FTD
FTD falls into three clinical subtypes, each defined by which symptoms appear first.
Behavioral variant FTD (bvFTD) is the most common form. It causes changes in personality and social behavior, often dramatic enough that family members describe the person as “becoming someone else.” Diagnosis requires at least three of six core features: social disinhibition (saying or doing inappropriate things), apathy or loss of motivation, loss of empathy or concern for others, repetitive or compulsive behaviors, overeating or fixating on certain foods, and difficulty with planning and problem-solving. Memory often remains relatively intact early on, which is one reason bvFTD is frequently misdiagnosed as a psychiatric condition like depression or late-onset bipolar disorder.
Semantic dementia gradually strips away a person’s knowledge of words and objects. Someone with this variant might look at a hammer and not know what it’s called or what it’s for. Speech stays fluent, meaning sentences sound grammatically normal, but the words lose their meaning. Over time, difficulty recognizing faces and understanding social situations develops as well.
Progressive nonfluent aphasia (PNFA) affects speech production rather than word meaning. People with PNFA speak haltingly, drop small grammatical words, and struggle to form sentences, though they still understand individual words. Behavioral problems and broader thinking difficulties tend to appear later in the course of the disease. Semantic dementia and PNFA are sometimes grouped together under the umbrella term “primary progressive aphasia,” or PPA.
How FTD Differs From Alzheimer’s Disease
The most important distinction is what goes wrong first. Alzheimer’s typically starts with forgetting recent events, names, and conversations. FTD starts with changes in behavior, personality, or language while memory for day-to-day events remains relatively spared. People with FTD also tend to perform better on tasks involving drawing and basic math compared to people with Alzheimer’s at a similar stage of impairment. The age difference matters too: FTD is equally as common as Alzheimer’s in people aged 45 to 64, affecting roughly 15 per 100,000 people in that age group.
These differences have practical consequences. Because FTD strikes during working years and doesn’t look like “typical” dementia, the average person waits years before getting the correct diagnosis. Personality changes may be attributed to stress, midlife crisis, or relationship problems before anyone considers a neurological cause.
What Happens in the Brain
In FTD, abnormal clumps of protein build up inside nerve cells in the frontal and temporal lobes, eventually killing them. Three proteins account for nearly all cases. About 45% of cases involve a protein called tau, which normally helps maintain the internal scaffolding that cells use to transport nutrients. When tau malfunctions, that transport system breaks down. Around 50% involve a protein called TDP-43, which normally lives in the cell’s nucleus and helps regulate how genetic instructions get carried out. The remaining 5% involve a related protein called FUS, which has a similar job.
The specific protein involved influences which symptoms appear and how quickly the disease progresses, but there is no reliable way to determine which protein is responsible during a person’s lifetime without specialized testing. Brain imaging can help with diagnosis: MRI scans typically show shrinkage of the frontal and temporal lobes, and PET scans can detect reduced brain activity in those regions even before visible shrinkage appears.
Genetics and Family History
About 10 to 20% of FTD cases are caused by an inherited gene mutation, a higher genetic contribution than most other forms of dementia. Three genes account for the majority of familial cases.
- C9orf72 is the most common genetic cause. Mutations in this gene can cause FTD, ALS (amyotrophic lateral sclerosis), or both conditions in the same person.
- MAPT mutations typically cause the behavioral variant and do not cause ALS. Some MAPT mutations produce symptoms that overlap with other movement disorders.
- GRN (progranulin) mutations can cause behavioral variant FTD, progressive language problems, or movement difficulties resembling Parkinson’s disease. Rarely, they also cause ALS.
The remaining 80 to 90% of cases are considered sporadic, meaning no clear inherited mutation is identified. Having a family member with FTD does not guarantee you will develop it, but genetic counseling can help families with a known history understand their risk.
How FTD Progresses
FTD is a progressive condition with no current cure. The timeline varies by subtype and whether motor neuron disease is also present. In cases without motor neuron involvement, life expectancy from the onset of symptoms ranges from roughly 7 to 13 years. One large clinical study found median survival of about 10.5 years for behavioral variant FTD and 12.6 years for the nonfluent aphasia variant. When FTD occurs alongside ALS, progression tends to be faster.
Early stages may be subtle enough that only close family members notice. Middle stages bring increasing dependence on caregivers as behavioral control, language, or both deteriorate further. In later stages, people with any subtype of FTD typically need full-time care, and swallowing difficulties, immobility, and infections become the primary medical concerns.
Treatment and Day-to-Day Management
No medication slows or stops FTD. Treatment focuses on managing symptoms. For behavioral symptoms like agitation, impulsivity, or compulsive behaviors, doctors sometimes prescribe antidepressants that increase serotonin levels in the brain. Small studies suggest these can reduce irritability and repetitive behaviors in some people. Antipsychotic medications are occasionally used for severe agitation, but side effects limit their usefulness, and they are prescribed cautiously.
For the language variants, speech therapy can help people develop compensatory strategies, like using picture boards or digital communication tools, especially in earlier stages when the person can still learn new approaches. Much of the day-to-day management falls to caregivers: simplifying the home environment, establishing consistent routines, reducing decision-making demands, and managing safety risks that arise from impulsive behavior or poor judgment. Caregiver burnout is a significant concern, since FTD often strikes when families have children at home, careers in progress, and no expectation of dealing with dementia.